Adding carboplatin to chemotherapy regimens for metastatic castrate-resistant prostate cancer in postsecond generation hormone therapy setting: Impact on treatment response and survival outcomes

Mohamed E. Ahmed, Jack R. Andrews, Jamal Alamiri, Julianna Higa, Rimki Haloi, Manaf Alom, Giovanni Motterle, Vidhu Joshi, Paras H. Shah, R. Jeffrey Karnes, Eugene Kwon

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Adding carboplatin to chemotherapy regimens for metastatic castrate-resistant prostate cancer in postsecond generation hormone therapy setting: Impact on treatment response and survival outcomes'. Together they form a unique fingerprint.

Medicine & Life Sciences